Vascular Access in Cancer Patients - PICC vs PORT in a Randomized Controlled Trial.

As of today there is very limited scientific knowledge in whicj of the two vascular access devices (PICC-line or venous ports) that offers the lowest complicationrates in cancerpatients. The study group wants to clearify this unsolved matter by comparing the two systems. Our primary endpoint is the presens of catheter related venous thrombosis. We are also looking at all catheter related complications and patient satisfaction.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Focus of Study

Age range

18 year–120 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dept of Oncology

Jönköping, 551 11, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

cancer treatment with need for central venous access
Age >18 yrs
Suspected survival > 4 weeks
Need of central venous access >4 weeks

Exclusion criteria

Ongoing uncontrolled systemic infection
Prescence of significant thrombosis/stenosis in arm or central veins
Unability to communicate
Probable upcoming need for dialysis fistula

Treatment and study plan

PICC or subcutaneous venous port

Device

Primary outcomes

The occurence of catheter related venous thrombosis

Time frame: Upon clinical suspiscion during the one the patient i enrolled in the study

regular follow-ups at month 1, 3, 6 and 12.

Sponsors and collaborators

Lead sponsor

Linkoeping University

Other Gov

Collaborators

Ryhov County Hospital

Registry information

Important dates

Study start: 2013
Primary completion: 2018
First posted: Oct 28, 2013
Registry last updated: Jan 30, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed